Metabolism of (4-14C) cholesterol by human adrenal glands in vitro and its inhibition by metyrapone.
D015065:17-Hydroxycorticosteroids / Q000096:biosynthesis; D000236:Adenoma / Q000378:metabolism; D000307:Adrenal Gland Diseases / Q000378:metabolism / Q000628:therapy; D000310:Adrenal Gland Neoplasms / Q000378:metabolism; D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism*; D000315:Adrenalectomy; D000308:Adrenocortical Hyperfunction / Q000378:metabolism; D000328:Adult; D000735:Androstenedione / Q000096:biosynthesis; D002250:Carbon Radioisotopes; D002784:Cholesterol / Q000378:metabolism*; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D003345:Corticosterone / Q000096:biosynthesis; D003864:Depression, Chemical; D003900:Desoxycorticosterone / Q000096:biosynthesis; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000096:biosynthesis; D066298:In Vitro Techniques; D008797:Metyrapone / Q000494:pharmacology*; D008875:Middle Aged; D011284:Pregnenolone / Q000378:metabolism; D011374:Progesterone / Q000378:metabolism; D014316:Tritium
D015065:17-Hydroxycorticosteroids; D002250:Carbon Radioisotopes; D014316:Tritium; D000735:Androstenedione; D003900:Desoxycorticosterone; D011374:Progesterone; D011284:Pregnenolone; D002784:Cholesterol; D003345:Corticosterone; D006854:Hydrocortisone; D008797:Metyrapone